CLL:LSE-Cello Health plc (GBX)

COMMON STOCK | Advertising Agencies | LSE

Last Closing Price

GBX 161.00

Change

0.00 (0.00)%

Market Cap

GBX 0.18B

Volume

0.01M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Cello Health plc, together with its subsidiaries, offers marketing services in the United Kingdom, the rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients. The Cello Signal segment offers market research and direct communications services principally to consumer-facing clients. Cello Health plc was incorporated in 2004 and is based in London, the United Kingdom. As of August 11, 2020, Cello Health plc operates as a subsidiary of Value Demonstration UK Holdings Limited.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-02-26 )

Largest Industry Peers for Advertising Agencies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WPP:LSE WPP plc

-13.60 (-1.57%)

GBX10.63B 11.56 5.61
SFOR:LSE S4 Capital plc

+16.00 (+3.74%)

GBX2.32B N/A 84.21
ASCL:LSE Ascential plc

-1.60 (-0.45%)

GBX1.44B 151.68 19.92
YOU:LSE YouGov plc

-10.00 (-1.03%)

GBX1.07B 113.18 36.94
TRMR:LSE Tremor International Ltd

-28.00 (-4.65%)

GBX0.80B 35.36 43.24
FOUR:LSE 4imprint Group plc

-60.00 (-2.40%)

GBX0.69B 25.05 16.42
NFC:LSE Next Fifteen Communications Gr..

-4.00 (-0.64%)

GBX0.57B 194.00 21.30
OOUT:LSE Ocean Outdoor Limited

+0.15 (+1.99%)

GBX0.41B N/A 15.61
PEBB:LSE The Pebble Group Plc

N/A

GBX0.23B 2.73 600.44
SAA:LSE M&C Saatchi plc

+11.00 (+7.86%)

GBX0.17B 3.83 10.28

ETFs Containing CLL

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Advertising Agencies)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 25.98% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.98% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 86.05% N/A N/A N/A N/A
Dividend Return 16.19% N/A N/A N/A N/A
Total Return 102.23% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.96% N/A N/A N/A N/A
Dividend Return 2.59% N/A N/A N/A N/A
Total Return 13.56% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.15% N/A N/A N/A N/A
Risk Adjusted Return 79.05% N/A N/A N/A N/A
Market Capitalization 0.18B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Advertising Agencies)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.10 N/A N/A N/A N/A
Price/Book Ratio 2.17 N/A N/A N/A N/A
Price / Cash Flow Ratio 14.05 N/A N/A N/A N/A
EV/EBITDA 13.95 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 5.70% N/A N/A N/A N/A
Return on Invested Capital 12.13% N/A N/A N/A N/A
Return on Assets 3.79% N/A N/A N/A N/A
Debt to Equity Ratio 3.68% N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.50 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBP)

Quarterly Financials (GBP)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike